Alkem Laboratories Limited (NSE:ALKEM)
5,368.00
-81.50 (-1.50%)
Aug 14, 2026, 3:15 PM IST
Alkem Laboratories Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Alkem Laboratories stock has a consensus rating of "Buy" and an average price target of ₹5,965. The average 1-year stock price forecast is 11.12% higher than the current stock price, while the lowest is ₹4,200 (-21.76%) and the highest is ₹6,890 (+28.35%).
Price Target: ₹5,965 (+11.12%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 29, 2026.
Analyst Ratings
The average analyst rating for Alkem Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 6 | 7 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 6 | 7 | 7 | 4 | 4 | 4 |
| Sell | 2 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 3 | 4 | 4 | 4 |
| Total | 21 | 21 | 21 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Maintains ₹5,900 | Hold | Maintains | ₹5,900 | +9.91% | May 29, 2026 |
| Jefferies | Jefferies | Buy Maintains ₹6,500 | Buy | Maintains | ₹6,500 | +21.09% | May 29, 2026 |
| ICICI Securities | ICICI Securities | Buy Maintains ₹6,500 → ₹6,850 | Buy | Maintains | ₹6,500 → ₹6,850 | +27.61% | May 28, 2026 |
Financial Forecast
Revenue This Year
166.21B
from 147.12B
Increased by 12.97%
Revenue Next Year
183.07B
from 166.21B
Increased by 10.14%
EPS This Year
197.25
from 204.53
Decreased by -3.56%
EPS Next Year
227.07
from 197.25
Increased by 15.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.